Investor Presentation First Nine Months of 2023 slide image

Investor Presentation First Nine Months of 2023

115 Investor presentation First nine months of 2023 GLP-1 market share and market growth 100% 80% 60% 40% 20% 0% GLP-1 market growth and Novo Nordisk market share Aug 2020 NN market share -Market growth (Right Axis) DKK billion 80% 84% 69% 60% 34 52% 40% 39% 20% 63% GLP-1 market size and growth -39% 2 47 11 ~52% 69% 0% Aug 2023 Aug 2022 Novo Nordisk Company A Others Aug 2023 NN share of growth Novo Nordisk Competitors NN growth (Right Axis) Source: IQVIA, Aug 2023, Value MAT, all countries; Due to contractual obligations competitor names are not disclosed. Company A represents an actual company. NN: Novo Nordisk; Market values are based on the list prices Novo NordiskⓇ
View entire presentation